SCISPARC
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.
SCISPARC
Industry:
Biotechnology Cannabis Medical
Founded:
2014-01-01
Address:
Giv'atayim, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.therapixbio.com
Total Employee:
11+
Status:
Active
Contact:
97236167055
Email Addresses:
[email protected]
Total Funding:
18.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS CPanel SSL CPanel
Similar Organizations
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-31 | MitoCareX Bio Ltd | SciSparc investment in Venture Round - MitoCareX Bio Ltd | 700 K USD |
| 2014-04-02 | LaraPharm | SciSparc investment in Venture Round - LaraPharm | 1.5 M USD |
Official Site Inspections
http://www.therapixbio.com
- Host name: 241.206.interhost.net
- IP address: 185.18.206.241
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
More informations about "SciSparc"
Therapix Biosciences Ltd. | LinkedIn
Therapix Biosciences Ltd. | 501 followers on LinkedIn. Therapix Biosciences Ltd. (NASDAQ: TRPX) is a specialty clinical-stage pharmaceutical company led by an experienced team of …See details»
Therapix Biosciences Ltd.: Contact Details and Business Profile
Therapix Biosciences Ltd. is a Pharmaceuticals, Pharmaceutical Manufacturing, and Drug Manufacturing & Research company_reader located in Giv`at Hayyim Ihud, Central District …See details»
Therapix Biosciences Ltd. - Company Profile & Staff Directory
Therapix Biosciences Ltd. (NASDAQ: TRPX) is a specialty clinical-stage pharmaceutical company led by an experienced team of Senior Executives and Scientists. Our focus is creating and …See details»
Therapix Biosciences Ltd (TRPXD) Profile - The Globe and Mail
See the company profile for Therapix Biosciences Ltd (TRPXD) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Therapix Biosciences - Company Profile - Tracxn
Therapix Biosciences - Developing cannabinoid-based therapies for CNS disorders. Acquired by FSD Pharma. Raised funding over 3 rounds from 1 investor.See details»
Therapix Biosciences Company Profile | Management and
Find contact information for Therapix Biosciences. Learn about their Business Services, Research & Development market share, competitors, and Therapix Biosciences's email format.See details»
Therapix Biosciences - M&A Summary and Business Overview
Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of Senior Executives and Scientists. Its focus is creating and enhancing a …See details»
Therapix Biosciences | VentureRadar
Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a …See details»
Therapix Biosciences Ltd. Overview | SignalHire Company Profile
Therapix Biosciences Ltd. is a public company that has been in the industry for 19 years. The company currently specializes in the Pharmaceuticals area. The position of the CEO is …See details»
Therapix Biosciences - Craft
Jan 28, 2021 Therapix Biosciences (formerly NasVax) is a specialty clinical-stage company that focuses on cannabinoid pharmaceuticals. It develops a range of drug candidates for the …See details»
Therapix Biosciences - Products, Competitors, Financials, …
About Therapix Biosciences Therapix Biosciences, fka NasVax, is a biopharmaceutical company that develops improved vaccines and immunotherapeutics. The company concentrates on …See details»
Therapix Biosciences Ltd. | ConnectPlex.ai
Therapix Biosciences Ltd. Details Therapix Biosciences Ltd. (NASDAQ: TRPX) is a specialty clinical-stage pharmaceutical company led by an experienced team of Senior Executives and …See details»
Therapix Biosciences : Announces Name Change to SciSparc Ltd.
TEL AVIV, Israel, Jan. 28, 2021 /PRNewswire/ -- SciSparc Ltd. (OTCQB: TRPXY), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based …See details»
SciSparc - Crunchbase Company Profile & Funding
SciSparc is a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments.See details»
Therapix Biosciences Appoints Prof. Ari Shamiss (M.D., M.P.A.) to …
May 7, 2020 "I have followed Therapix for several years and I look forward to be a part of the organization," said Prof. Shamiss. "Therapix's technology has the potential to create game …See details»
Therapix Biosciences Ltd. - Cruelty Free Investing
Our Opinion Therapix Biosciences Ltd. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical …See details»
Therapix Biosciences Announces Canadian Product License
TEL AVIV, Israel, July 31 2019 /PRNewswire Therapix Biosciences Ltd. (“ Therapix ” or the “ Company ”) (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing …See details»
Therapix Biosciences Initiates Non-clinical Studies for its ...
Oct 30, 2017 Therapix has initiated non-clinical studies to evaluate the efficacy of its proprietary compound THX-150, a pharma composition of dronabinol in collaboration with the Weizmann …See details»
Therapix Biosciences and Cyntar Ventures Entered a Non-Binding …
Jan 5, 2021 Therapix Biosciences and Cyntar Ventures Entered a Non-Binding Letter of Intent for the Distribution of TheraPEA in Canada Therapix's TheraPEA product has all required …See details»
Therapix Biosciences and Cyntar Ventures Entered a Non-Binding …
Jan 5, 2021 Therapix Biosciences and Cyntar Ventures Entered a Non-Binding Letter of Intent for the Distribution of TheraPEA in Canada | SPRC - SciSparc Ltd.See details»